Email Alert | RSS    帮助

中国防痨杂志 ›› 2012, Vol. 34 ›› Issue (3): 150-153.

• 论著 • 上一篇    下一篇

我国卡介苗保护力评价参考体系建立的探讨

陈保文 沈小兵 都伟欣 苏城 杨蕾 卢锦标 王国治   

  1. 100050北京,中国食品药品检定研究院细菌一室
  • 收稿日期:2012-01-10 出版日期:2012-03-10 发布日期:2012-05-03
  • 通信作者: 王国治 E-mail:tbtestlab@163.net
  • 基金资助:

    “十一五“国家重大科技专项(2009zx10004-803)

Development of BCG reference system of evaluating the protective efficacy of vaccine in China

CHEN Bao-wen,SHEN Xiao-bing,DU Wei-xin,SU Cheng,YANG Lei,LU Jin-biao,WANG Guo-zhi   

  1. The first Division of Bacterial Vaccines,National Institutes for Food and Drug Control,Beijing 100050, China
  • Received:2012-01-10 Online:2012-03-10 Published:2012-05-03
  • Contact: WANG Guo-zhi E-mail:tbtestlab@163.net

摘要: 目的  探讨我国结核病新疫苗评价用卡介苗参考体系对豚鼠的保护力。 方法  采用我国卡介苗(D2  PB 302)菌株制备的疫苗,以1/10人用剂量(0.005 mg/0.2 ml)经皮下注射免疫豚鼠,对照组等体积注射生理盐水。共进行4个实验,免疫与感染间隔分别为:实验Ⅰ与Ⅱ免疫后进行Mtb感染的时间间隔为5周(其中实验Ⅱ为实验Ⅰ的重复实验,实验Ⅰ中BCG组和对照组均入组8只豚鼠;实验Ⅱ中BCG组入组6只豚鼠,对照组入组8只豚鼠),实验Ⅲ为28周(BCG组入组5只豚鼠,对照组入组6只豚鼠),实验Ⅳ为60周(BCG组和对照组均入组8只豚鼠),感染剂量为每只豚鼠2×(102~103)CFU Mtb/ml,注射0.5 ml,感染途径为皮下注射,感染后6周,进行豚鼠解剖,观察豚鼠肝脾肺的病变程度并进行脾脏Mtb的分离,计算脾脏Mtb分离数和对数值。 结果(1) BCG免疫5周组,豚鼠的肝脾肺综合病变指数为10.0±3.8,较对照组(46.9±4.8)差异有显著统计学意义(t=-0.63, P<0.01);脾脏Mtb分离数的对数值(lg)为0.49±0.49,较对照组(5.41±0.18)差异有显著统计学意义(t=-9.43, P<0.01)。(2)BCG免疫5周重复实验组,豚鼠的肝脾肺综合病变指数为6.7±2.1,较对照组(36.3±6.0)差异有显著统计学意义(t=-4.63, P<0.01);脾脏Mtb分离数的对数值(lg)为0.38±0.38,较对照组(5.11±0.19)差异有显著统计学意义(t=-11.22, P<0.01)。(3)BCG免疫28周组,豚鼠的肝脾肺综合病变指数为10.0±4.5,较对照组(57.5±6.2)差异有显著统计学意义(t=-6.24, P<0.01);脾脏Mtb分离数的对数值(lg)为2.16±0.93,较对照组(5.44±0.27)差异有统计学意义(t=-3.39, P<0.05)。(4)BCG免疫60周组,豚鼠的肝脾肺综合病变指数为14.4±4.8,较对照组(56.9±5.0)差异有显著统计学意义(t=-6.16, P<0.01);脾脏Mtb分离数的对数值(lg)为1.46±0.69,较对照组(5.43±0.20)差异有显著统计学意义(t=-5.55, P<0.01)。  结论  卡介苗保护力评价参考体系可靠稳定,我国临床应用卡介苗在该体系呈现优良保护效果。

关键词: 卡介苗, 治疗结果, 疾病模型, 动物, 评价研究

Abstract: Objective  To develop BCG reference system to evaluate protective efficacy of new tuberculosis vaccine in China.  Methods  The guinea pigs were immunized by subcutaneous injection with 1/10 human dose (0.005 mg/0.2 ml) of BCG strains (D 2 PB 302), and the saline was used as the control. A total of 4 experiments were performed respectively. Each guinea pig was infected by subcutaneous injection with 0.5 ml of Mtb suspension (200 to 2000 CFU/ml) at 5 weeks (testⅠand test Ⅱ), 28 weeks (test Ⅲ), and 60 weeks (test Ⅳ) after immunization, respectively. The guinea pigs were sacrificed 6 weeks after the infection. The pathological changes of livers, spleens and lungs of the guinea pigs were observed. The spleens were taken, homogenized and then cultured. Mtb colonies in the spleens were enumerated and the results were expressed as logarithm values. Results The lesion indexes of livers, spleens and lungs in test Ⅰ, Ⅱ, Ⅲ, Ⅳ were (10.0±3.8), (6.7±2.1), (10.0±4.5), and (14.4±4.8), respectively, significantly lower than those in the control groups[(46.9±4.8),  t=-0.63,  P<0.01; (36.3±6.0),  t=-4.63,  P<0.01; (57.5±6.2),  t=-6.24,  P<0.01; (56.9±5.0),  t=-6.16,  P<0.01, respectively]. Mtb colonies in the spleens in test Ⅰ, Ⅱ, Ⅲ, Ⅳ were lg (0.49±0.49), lg (0.38±0.38),  lg (2.16±0.93), and lg (1.46±0.69), respectively, significantly lower than those in the control groups[lg (5.41±0.18), t=-9.43, P<0.01; lg (5.11±0.19),  t=-11.22,  P<0.01; lg (5.44±0.27),  t=-3.39,  P<0.05; lg (5.43±0.20),  t=-5.55, P<0.01, respectively]. Conclusion  BCG reference system used to evaluate protective efficacy of new tuberculosis vaccine is reliable and stable. The BCG used in our country exhibits excellent protective efficacy.

Key words: BCG vaccine, Treatment outcome,  , Disease models, animal, Evaluation studies